Too much disclosure of product risks? CBC television, SOGC, and Diane-35.
Mintzes
Barbara
B
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC, Canada.
Lexchin
Joel
J
Lippman
Abby
A
Ford
Anne Rochon
AR
D000152:Acne Vulgaris / Q000188:drug therapy; D000329:Advertising; D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D002170:Canada; D017373:Cyproterone Acetate / Q000009:adverse effects* / Q000627:therapeutic use; D030881:Disclosure; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016017:Odds Ratio; D012307:Risk Factors; D014481:United States; D020246:Venous Thrombosis / Q000139:chemically induced*
D000726:Androgen Antagonists; D004338:Drug Combinations; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; C032640:Cyproterone acetate, ethinyl estradiol drug combination